Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: J Allergy Clin Immunol. 2019 Sep 23;145(1):119–126.e4. doi: 10.1016/j.jaci.2019.08.038

Table 2.

Effect of Combined Major Roadway Proximity on Asthma Symptoms

Unadjusted Analyses Adjusted* Analyses
Effect estimates are based on each 100m farther away from major roadway
OR (95% CI)
n=350
p-value OR (95% CI)
n=350
p-value
Primary Outcome
Components
Maximum Symptom Days *** 0.68 (0.53 – 0.87) p<0.01 0.71 (0.58 – 0.87) p<0.01
Daytime Wheeze** 0.70 (0.54 – 0.91) p<0.01 0.76 (0.61 – 0.95) p=0.02
Limitations in Activities*** 0.62 (0.42 – 0.90) p=0.01 0.61 (0.43 – 0.88) p<0.01
Nighttime Wheeze 0.71 (0.49 – 1.04) p=0.08 0.79 (0.59 – 1.05) p=0.10
Secondary Outcomes
Health Care Utilization*** 0.69 (0.52 – 0.92) p=0.01 0.63 (0.47 – 0.85) p<0.01
Missed School Days 0.85 (0.41 – 1.78) p=0.66 0.97 (0.54 – 1.74) p=0.92
Caregiver Plans Changed 0.72 (0.41 – 1.25) p=0.24 0.73 (0.43 – 1.24) p=0.24
Caregiver Lost Sleep 0.69 (0.46 – 1.01) p=0.06 0.75 (0.54 – 1.06) p=0.10
Composite Poor Asthma*** 0.77 (0.65 – 0.92) p<0.01 0.80 (0.69 – 0.94) p<0.01
Spirometry Outcomes β (95% CI)
n=327
p-value β (95% CI)
n=327
p-value
FEV1, % predicted −1.02 (−4.57 – 2.54) p=0.58 −0.44 (−4.20 – 3.31) p=0.82
FVC, % predicted −2.77 (−5.45 - −0.10) p=0.04 −2.26 (−5.15 – 0.64) p=0.13
FEV1/FVC, percent** 1.39 (0.18 – 2.60) p=0.03 1.39 (0.18 – 2.60) p=0.03
FEF25–75, % predicted −2.60 (−10.76 – 5.56) p=0.53 −2.77 (−10.93 – 5.39) p=0.51

FEV1: Forced expiratory volume in one second; FVC: Forced Vital Capacity; FEV1/FVC: The percent of forced expiratory volume in one second over forced vital capacity; FEF25–75: Forced expiratory flow at 25–75% of the forced vital capacity.

*

Adjusted for: age, sex, race/ethnicity, annual household income, environmental tobacco smoke, controller medication, recent upper respiratory infections, and seasonality. Models for FEV1, % predicted and FEF25–75, % predicted did not adjust separately for age, sex, and race/ethnicity as these are included in the percent prediction estimates.

**

p<0.05 in adjusted analyses;

***

p<0.01 in adjusted analyses.

Includes all study participants (n=1327 observations; n=350 participants) and corresponding spirometry outcomes (n=645 observations; n=327 participants)